JAMA Pediatrics has published research on the impact of policy on child health to inform decision-making with scientific evidence. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, MPH, and Associate Editor Alison Galbraith, MD, MPH, discuss policy issues raised by these studies with Aaron Carroll, MD, MS, President and CEO of Academy Health and an Associate Editor at JAMA Pediatrics. Related Content:

• Transgender Adolescent School Climate, Mental Health, and Adult Social Support
• Mandatory Child Protective Services Reporting for Substance-Exposed Newborns and Peripartum Outcomes
• Guiding Child Health Policy With Science
• Real-Time Exposure to Negative News Media and Suicidal Ideation Intensity Among LGBTQ+ Young Adults

A new study finds an increased risk of major adverse cardiovascular events in adulthood after incident diagnosis of hypertension in childhood. Stephen Daniels, MD, PhD, of the University of Colorado discusses hypertension screening and treatment of children and adolescents with JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, MPH, and JAMA Pediatrics Associate Editor Alison Galbraith, MD, MPH. Related Content:

• Long-Term Cardiovascular Outcomes in Children and Adolescents With Hypertension

A meta-analysis of treatments for autism finds that increasing intervention is not associated with greater improvement in development for young children with autism. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, and JAMA Pediatrics Associate Editor Alison Galbraith, MD, discuss autism treatments with Geraldine Dawson, PhD, Director of the Duke Center for Autism and Brain Development. Related Content:

• Determining Associations Between Intervention Amount and Outcomes for Young Autistic Children

New research finds that iron supplementation for low-risk breastfed infants born at term does not improve psychomotor development. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, MPH, and JAMA Pediatrics Associate Editor Alison Galbraith, MD, MPH, discuss infant iron supplementation with Martha Sola-Visner, MD, associate professor at Boston Children’s Hospital and Harvard Medical School. Related Content:

• Effect of Low-Dose Iron Supplementation on Early Development in Breastfed Infants

New research finds that an artificial intelligence decision support tool has high accuracy for diagnosing otitis media. Bimal Desai, MD, MBI, Chief Health Informatics Officer at Children’s Hospital of Philadelphia, discusses applications of artificial intelligence in pediatric care with Editor in Chief Dimitri A. Christakis, MD, MPH, and Associate Editor Alison A. Galbraith, MD, MPH. Related Content:

• Development and Validation of an Automated Classifier to Diagnose Acute Otitis Media in Children

A new systematic review and meta-analysis supports recommendations to limit 100% fruit juice consumption for children and adults to prevent weight gain. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, and JAMA Pediatrics Associate Editor Alison Galbraith, MD, discuss strategies to address pediatric and adolescent obesity with Thomas Robinson, MD, MPH, of Stanford University. Related Content:

• Consumption of 100% Fruit Juice and Body Weight in Children and Adults

New research shows that HPV vaccination rates have increased, and interventions targeted to parents and health care professionals can improve rates. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, and JAMA Pediatrics Associate Editor Alison Galbraith, MD, discuss strategies to increase HPV vaccination with Melissa Gilkey, PhD, of the University of North Carolina's Gillings School of Global Public Health. Related Content:

• Multilevel Implementation Strategies for Adolescent Human Papillomavirus Vaccine Uptake
• Trends in HPV Vaccination Before Age 13 Years in the US National Immunization Survey–Teen

Two recent studies find that COVID-19 vaccination during pregnancy is safe for infants and effective for children aged 1-4 years. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, and JAMA Pediatrics Associate Editor Alison Galbraith, MD, discuss clinical and policy implications with Grace Lee, MD, MPH, professor of Pediatrics at Stanford University School of Medicine, Palo Alto, California. Related Content:

• Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy
• Effectiveness of Monovalent mRNA Vaccines Against Omicron XBB Infection in Singaporean Children Younger Than 5 Years

Screen use by children is common and can affect child development, with effects varying by age and developmental domain. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, and JAMA Pediatrics Associate Editor Alison A. Galbraith, MD, discuss evidence about screen use across childhood and strategies to reduce negative impacts with Sheri Madigan, PhD, RPsych, of the University of Calgary, Calgary, Alberta, Canada. Related Content:

• Screen Time at Age 1 Year and Communication and Problem-Solving Developmental Delay at 2 and 4 Years

Firearm suicide takes the lives of thousands of US youths annually, and the economic burden of youth violence is high, especially from male firearm homicides. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, and JAMA Pediatrics Associate Editor Alison A. Galbraith, MD, discuss the burden of gun violence and prevention of firearm-related injuries with JAMA Network Open Editor Frederick P. Rivara, MD, MPH, of the Seattle Children’s Hospital. Related Content:

• Years of Life Lost to Firearm Suicide Among Young People in the US
• Economic Burden of US Youth Violence Injuries

Treatment with buprenorphine is approved and effective for adolescents with opioid use disorder (OUD) but is underused. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, and JAMA Pediatrics Associate Editor Alison A. Galbraith, MD, discuss diagnosis and treatment of OUD with Scott Hadland, MD, Chief of Adolescent Medicine at Massachusetts General Hospital, Boston, and an expert in adolescent OUD.  Related Content:

• Out-of-Pocket Costs and Payer Types for Buprenorphine Among US Youth Aged 12 to 19 Years

Conflict of Interest disclosures:

Dr Hadland has received honoraria from the American Academy of Pediatrics for speaking on the topic of adolescent opioid use disorder treatment.